ADDERALL


What it isStimulant that releases norepinephrine, dopamine and serotonin; ADHD and narcolepsy.
Why this oneIts release mechanism can work when methylphenidate reuptake blockade has not, but it carries greater misuse pressure.
What limits itAppetite loss, insomnia and blood-pressure rise often limit it. Schedule II diversion matters; urinary alkalinization can raise exposure.
Animated chart of estimated U.S. prescriptions per year, ADHD meds (1938–2026). Mixed amphetamine salts enters in 1996 (estimated).
Legacy pregnancy categoryC
Defining liabilityMisuse, hypertension, hyperthermia, psychosis and potentially fatal sympathomimetic toxicity.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Narcolepsy | Adults and ≥12 yr | 10 mg QD | 5–60 mg/day in divided doses (usual) | Undefined |
| ADHD | Children 3–5 yr | 2.5 mg QD | Titrate to optimal response | Undefined |
| ADHD | Children ≥6 yr | 5 mg QD–BID | Titrate to optimal response | Rarely need >40 mg/day |
| Narcolepsy | Children 6–12 yr | 5 mg QD | Titrate to optimal response | Undefined |
Titration Weekly intervals (ADHD: +2.5 mg/day age 3–5, +5 mg/day ≥6 yr; narcolepsy: +5 mg/day age 6–12, +10 mg/day ≥12 yr)
Renal Undefined
Hepatic Undefined
Not recommended under 3 yr of age.
Available strengths
Pregnancy No adequate human studies; infants of amphetamine-dependent mothers risk prematurity, low birth weight, and withdrawal.
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 5 mg | tab | per unit | $0.26/ea | not offered |
| 7.5 mg | tab | per unit | $0.28/ea | not offered |
| 10 mg | tab | per unit | $0.23/ea | not offered |
| 12.5 mg | tab | per unit | $0.36/ea | not offered |
| 15 mg | tab | per unit | $0.24/ea | not offered |
| 20 mg | tab | per unit | $0.29/ea | not offered |
| 30 mg | tab | per unit | $0.30/ea | not offered |
Other forms: Mixed amphetamine salts XR (ADDERALL XR) · Mixed amphetamine salts (triple-bead) (MYDAYIS)
Generic entry1984
Provisional washout figures
Elevating mechanismNone identified
Non-elevating actionNone recorded
Exposure dependenceNo serotonin-elevating mechanism identified
Evidence confidenceModerate
InterpretationNo clinically meaningful serotonin-elevating mechanism identified in this first-pass Gillman-based review.
Open Mixed amphetamine salts in the interactive console ↗

Open Mixed amphetamine salts in the interactive console ↗